통증 패치 시장 : 유형별, 용도별, 기술별, 제형별, 처방별, 환자 연령별, 점착 특성별, 작용 시간별, 약제 클래스별, 유통 채널별, 지역별

Pain Patch Market is estimated to be valued at USD 5.83 Bn in 2025 and is expected to reach USD 8.2 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5% from 2025 to 2032.

Pain patches, also known as transdermal patches, are adhesive patches that deliver medication directly through the skin to provide localized pain relief. These patches are convenient, easy to use, and offer a controlled release of medication over an extended period.

Market Dynamics:

The pain patch market is primarily driven by the increasing prevalence of chronic pain conditions, such as arthritis, back pain, and neuropathic pain. These conditions require long-term pain management solutions, and pain patches offer a convenient and effective option. Moreover, the rising awareness about the potential risks associated with oral pain medications, such as addiction and gastrointestinal side effects, is shifting the focus towards non-invasive drug delivery systems like pain patches.

However, the market growth may be hindered by certain factors. The high cost of pain patches compared to traditional pain medications and the limited availability of reimbursement for these products in some regions may restrict market expansion. Additionally, the stringent regulatory requirements for the approval of pain patches and the risk of skin irritation or allergic reactions associated with patch usage pose challenges to market growth.

Despite these challenges, the pain patch market presents several opportunities for growth. The increasing adoption of advanced technologies, such as wireless connectivity and sensor integration in pain patches, opens up avenues for innovation and product differentiation. Furthermore, the untapped potential of emerging markets and the growing demand for personalized pain management solutions provide opportunities for market players to expand their presence and cater to a diverse consumer base.

Key features of the study:

• This report provides in-depth analysis of the global pain patch market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global pain patch market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Hisamitsu Pharmaceutical Co., Inc., Johnson & Johnson, Pfizer Inc., Novartis AG, Mylan N.V., Endo Pharmaceuticals, Teikoku Pharma USA, Inc., Acorda Therapeutics, Ibsa Institut Biochimique SA, Alembic Pharmaceuticals, Noven Pharmaceuticals, Inc., Teva Pharmaceuticals, Strativa Pharmaceuticals, Galen Limited, and Napp Pharmaceuticals
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global pain patch market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pain patch market

Detailed Segmentation:

• Global Pain Patch Market, By Type
  • Opioid Pain Patches
  • Non-Opioid Pain Patches
• Global Pain Patch Market, By Application
  • Chronic Pain Patches
  • Acute Pain Patches
• Global Pain Patch Market, By Technology
  • Traditional Drug Delivery Patches
  • Advanced Drug Delivery Patches
• Global Pain Patch Market, By Formulation
  • Single Medication Patches
  • Combination Therapy Patches
• Global Pain Patch Market, By Prescription
  • Prescription Pain Patches
  • Over-the-Counter (OTC) Pain Patches
• Global Pain Patch Market, By Patient Age
  • Adult Pain Patches
  • Pediatric Pain Patches
• Global Pain Patch Market, By Adhesive Properties
  • Hypoallergenic Patches
  • Standard Adhesive Patches
• Global Pain Patch Market, By Duration of Action
  • Short-Acting Patches
  • Extended-Release Patches
• Global Pain Patch Market, By Drug Class
  • NSAID Patches
  • Local Anesthetic Patches
  • Other Medication Patches
• Global Pain Patch Market, By Distribution Channel
  • Retail Pharmacies
  • Hospitals and Clinics
• Global Pain Patch Market, By Geography
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
• Company Profiles
  • Hisamitsu Pharmaceutical Co., Inc.
  • Johnson & Johnson
  • Pfizer Inc.
  • Novartis AG
  • Mylan N.V.
  • Endo Pharmaceuticals
  • Teikoku Pharma USA, Inc.
  • Acorda Therapeutics
  • Ibsa Institut Biochimique SA
  • Alembic Pharmaceuticals
  • Noven Pharmaceuticals, Inc.
  • Teva Pharmaceuticals
  • Strativa Pharmaceuticals
  • Galen Limited
  • Napp Pharmaceuticals

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet , By Type
  • Market Snippet , By Application
  • Market Snippet , By Technology
  • Market Snippet , By Formulation
  • Market Snippet , By Prescription
  • Market Snippet , By Patient Age
  • Market Snippet , By Adhesive Properties
  • Market Snippet , By Duration of Action
  • Market Snippet , By Drug Class
  • Market Snippet , By Distribution Channel
  • Market Snippet , By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Growing demand for effective pain relief and non-invasive treatment
  • Skin Sensitivity and Irritation
  • Emergence of Personalized Pain Management
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Pain Patch Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Pain Patch Market, By Type, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Opioid Pain Patches
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Non-Opioid Pain Patches
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

6. Pain Patch Market, By Application, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Chronic Pain Patches
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Acute Pain Patches
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

7. Pain Patch Market, By Technology, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Traditional Drug Delivery Patches
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Advanced Drug Delivery Patches
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

8. Pain Patch Market, By Formulation, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Single Medication Patches
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Combination Therapy Patches
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

9. Pain Patch Market, By Prescription, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Prescription Pain Patches
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Over-the-Counter (OTC) Pain Patches
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

10. Pain Patch Market, By Patient Age, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Adult Pain Patches
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Pediatric Pain Patches
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

11. Pain Patch Market, By Adhesive Properties, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hypoallergenic Patches
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Standard Adhesive Patches
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

12. Pain Patch Market, By Duration of Action, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Short-Acting Patches
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Extended-Release Patches
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

13. Pain Patch Market, By Drug Class, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• NSAID Patches
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Local Anesthetic Patches
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Other Medication Patches
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

14. Pain Patch Market, By Distribution Channel, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Hospitals and Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

15. Pain Patch Market, By Region, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, By Country, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Country 2021 -2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Adhesive Properties, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Duration of Action, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Adhesive Properties, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Duration of Action, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Adhesive Properties, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Duration of Action, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Adhesive Properties, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Duration of Action, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Adhesive Properties, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Duration of Action, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Adhesive Properties, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Duration of Action, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • South Africa
    • Central Africa
    • North Africa

16. Competitive Landscape

• Hisamitsu Pharmaceutical Co., Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Johnson & Johnson
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Pfizer Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Novartis AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Mylan N.V.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Endo Pharmaceuticals
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Teikoku Pharma USA, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Acorda Therapeutics
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Ibsa Institut Biochimique SA
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Alembic Pharmaceuticals
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Noven Pharmaceuticals, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Teva Pharmaceuticals
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Strativa Pharmaceuticals
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Galen Limited
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Napp Pharmaceuticals
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Analyst Views

17. Section

• Research Methodology
• About us